AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.91
+0.13
(+0.94%)
Pre-Market: 08:03
AbCellera Biologics Price : 13.78 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 13.72 | 13.88 | 13.21 | 13.78 | 4.075M |
| Oct 02, 2026 | 14.10 | 14.30 | 13.66 | 13.74 | 3.714M |
| Oct 01, 2026 | 14.58 | 14.65 | 13.79 | 13.91 | 7.789M |
| Sep 30, 2026 | 14.78 | 15.02 | 14.56 | 14.59 | 4.864M |
| Sep 29, 2026 | 14.23 | 15.00 | 14.10 | 14.82 | 9.110M |
| Sep 28, 2026 | 12.44 | 14.23 | 12.38 | 13.92 | 7.832M |
| Sep 25, 2026 | 12.74 | 12.93 | 12.29 | 12.70 | 3.384M |
| Sep 24, 2026 | 12.02 | 12.68 | 11.78 | 12.65 | 4.991M |
| Sep 23, 2026 | 12.54 | 12.65 | 12.10 | 12.31 | 3.855M |
| Sep 22, 2026 | 12.56 | 12.97 | 12.49 | 12.65 | 4.285M |
| Sep 21, 2026 | 12.88 | 12.90 | 12.43 | 12.66 | 4.427M |
| Sep 18, 2026 | 12.73 | 12.96 | 12.37 | 12.63 | 5.438M |
| Sep 17, 2026 | 12.15 | 13.18 | 11.99 | 12.73 | 8.045M |
| Sep 16, 2026 | 11.44 | 11.73 | 11.18 | 11.67 | 4.545M |
| Sep 15, 2026 | 11.17 | 11.69 | 10.90 | 11.41 | 3.729M |
| Sep 14, 2026 | 10.66 | 11.30 | 10.66 | 11.17 | 4.448M |
| Sep 11, 2026 | 10.55 | 10.96 | 10.32 | 10.89 | 4.378M |
| Sep 10, 2026 | 10.79 | 11.07 | 10.42 | 10.46 | 4.945M |
| Sep 09, 2026 | 11.37 | 11.45 | 11.01 | 11.05 | 2.412M |
| Sep 08, 2026 | 11.29 | 11.64 | 11.10 | 11.44 | 2.559M |
| Sep 04, 2026 | 11.50 | 11.59 | 11.33 | 11.43 | 2.019M |
| Sep 03, 2026 | 11.58 | 11.82 | 11.26 | 11.57 | 3.292M |
| Sep 02, 2026 | 11.39 | 11.57 | 10.80 | 11.36 | 3.726M |
| Sep 01, 2026 | 11.24 | 11.52 | 11.05 | 11.28 | 4.251M |
| Aug 31, 2026 | 11.10 | 11.58 | 10.83 | 11.48 | 4.956M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| MindWalk Holdings Corp. | 1.49 |
| Repligen Corp. | 189.50 |
| Bio-Techne Corp. | 72.58 |
| Aurinia Pharmaceuticals, Inc. | 15.72 |
| BioLife Solutions, Inc. | 38.61 |
Price Related Metrics
| PS Ratio | 62.89 |
| Price to Book Value | 4.713 |
| Earnings Yield | -3.95% |
| Market Cap | 4.223B |